These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 25019594

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis.
    Caley MP, Kogianni G, Adamarek A, Gronau JH, Rodriguez-Teja M, Fonseca AV, Mauri F, Sandison A, Rhim JS, Pchejetski D, Palmieri C, Cobb JP, Waxman J, Sturge J.
    J Pathol; 2012 Apr; 226(5):775-83. PubMed ID: 22072289
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The collagen receptor uPARAP/Endo180.
    Engelholm LH, Ingvarsen S, Jürgensen HJ, Hillig T, Madsen DH, Nielsen BS, Behrendt N.
    Front Biosci (Landmark Ed); 2009 Jan 01; 14(6):2103-14. PubMed ID: 19273187
    [Abstract] [Full Text] [Related]

  • 5. Early reversal cells in adult human bone remodeling: osteoblastic nature, catabolic functions and interactions with osteoclasts.
    Abdelgawad ME, Delaisse JM, Hinge M, Jensen PR, Alnaimi RW, Rolighed L, Engelholm LH, Marcussen N, Andersen TL.
    Histochem Cell Biol; 2016 Jun 01; 145(6):603-15. PubMed ID: 26860863
    [Abstract] [Full Text] [Related]

  • 6. Uptake of denatured collagen into hepatic stellate cells: evidence for the involvement of urokinase plasminogen activator receptor-associated protein/Endo180.
    Mousavi SA, Sato M, Sporstøl M, Smedsrød B, Berg T, Kojima N, Senoo H.
    Biochem J; 2005 Apr 01; 387(Pt 1):39-46. PubMed ID: 15506989
    [Abstract] [Full Text] [Related]

  • 7. The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers.
    Nielsen CF, van Putten SM, Lund IK, Melander MC, Nørregaard KS, Jürgensen HJ, Reckzeh K, Christensen KR, Ingvarsen SZ, Gårdsvoll H, Jensen KE, Hamerlik P, Engelholm LH, Behrendt N.
    Oncotarget; 2017 Jul 04; 8(27):44605-44624. PubMed ID: 28574834
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces.
    Caley MP, King H, Shah N, Wang K, Rodriguez-Teja M, Gronau JH, Waxman J, Sturge J.
    Clin Exp Metastasis; 2016 Feb 04; 33(2):151-65. PubMed ID: 26567111
    [Abstract] [Full Text] [Related]

  • 11. uPARAP/Endo180: a multifaceted protein of mesenchymal cells.
    Gucciardo F, Pirson S, Baudin L, Lebeau A, Noël A.
    Cell Mol Life Sci; 2022 Apr 22; 79(5):255. PubMed ID: 35460056
    [Abstract] [Full Text] [Related]

  • 12. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.
    J Bone Miner Res; 2004 Nov 22; 19(11):1873-81. PubMed ID: 15476588
    [Abstract] [Full Text] [Related]

  • 13. Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180.
    Engelholm LH, Melander MC, Hald A, Persson M, Madsen DH, Jürgensen HJ, Johansson K, Nielsen C, Nørregaard KS, Ingvarsen SZ, Kjaer A, Trovik CS, Laerum OD, Bugge TH, Eide J, Behrendt N.
    J Pathol; 2016 Jan 22; 238(1):120-33. PubMed ID: 26466547
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K.
    Dan Med Bull; 2011 May 22; 58(5):B4277. PubMed ID: 21535989
    [Abstract] [Full Text] [Related]

  • 18. Re-thinking the bone remodeling cycle mechanism and the origin of bone loss.
    Delaisse JM, Andersen TL, Kristensen HB, Jensen PR, Andreasen CM, Søe K.
    Bone; 2020 Dec 22; 141():115628. PubMed ID: 32919109
    [Abstract] [Full Text] [Related]

  • 19. Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases.
    Parikka V, Väänänen A, Risteli J, Salo T, Sorsa T, Väänänen HK, Lehenkari P.
    Matrix Biol; 2005 Sep 22; 24(6):438-47. PubMed ID: 16098718
    [Abstract] [Full Text] [Related]

  • 20. The non-phagocytic route of collagen uptake: a distinct degradation pathway.
    Madsen DH, Ingvarsen S, Jürgensen HJ, Melander MC, Kjøller L, Moyer A, Honoré C, Madsen CA, Garred P, Burgdorf S, Bugge TH, Behrendt N, Engelholm LH.
    J Biol Chem; 2011 Jul 29; 286(30):26996-7010. PubMed ID: 21652704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.